{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04134728: Phase 3 Interventional Completed Arthritis, Rheumatoid
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03820531: Not Applicable Interventional Completed Pancreas Cyst
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03811028: Phase 1/Phase 2 Interventional Completed Sanfilippo Syndrome Type A (MPS IIIA)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04058028: Phase 2 Interventional Completed Systemic Lupus Erythematosus (SLE)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03295942: Phase 1 Interventional Terminated Locally Advanced Malignant Neoplasm
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03921541: Phase 3 Interventional Completed Arginase I Deficiency
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04665856: Phase 3 Interventional Active, not recruiting Small Cell Lung Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472145: Phase 2/Phase 3 Interventional Completed Leukemia, Myeloid, Acute
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sirtratumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01963052: Phase 1 Interventional Completed Metastatic Urothelial Cancer
(2013)
Source URL:
Class:
PROTEIN
